EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
2022 · Annals of the Rheumatic Diseases · 1,636 citations
https://doi.org/10.1136/ard-2022-223356
K
Kim Lauper
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
4.0K
Citations
23
h-index
36
i10-index
Kim Lauper is an academic researcher from University of Geneva. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Systemic Lupus Erythematosus Research & Biosimilars and Bioanalytical Methods. The author has an h-index of 23, co-authored 95 publications.
ORCID: 0000-0002-4315-9009Papers by this author
worksGlobal epidemiology of rheumatoid arthritis
2022 · Nature Reviews Rheumatology · 674 citations
https://doi.org/10.1038/s41584-022-00827-y
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
2022 · Annals of the Rheumatic Diseases · 199 citations
https://doi.org/10.1136/ard-2022-223335
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
2022 · Annals of the Rheumatic Diseases · 138 citations
https://doi.org/10.1136/annrheumdis-2022-222586
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
2020 · Lara D. Veeken · 90 citations
https://doi.org/10.1093/rheumatology/keaa393
Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status
2022 · Clinical Infectious Diseases · 66 citations
https://doi.org/10.1093/cid/ciac947
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat